title: DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia.
authors.affiliation: a Department of Leukemia , The University of Texas, M.D. Anderson Cancer Center , Houston , TX , USA ;
authors.forename: Preetesh
authors.initials: P
authors.lastname: Jain
authors.affiliation: a Department of Leukemia , The University of Texas, M.D. Anderson Cancer Center , Houston , TX , USA ;
authors.forename: Srdan
authors.initials: S
authors.lastname: Verstovsek
authors.affiliation: b Department of Hematopathology , The University of Texas, M.D. Anderson Cancer Center , Houston , TX , USA ;
authors.forename: Wei
authors.initials: W
authors.lastname: Wang
authors.affiliation: b Department of Hematopathology , The University of Texas, M.D. Anderson Cancer Center , Houston , TX , USA ;
authors.forename: Sanam
authors.initials: S
authors.lastname: Loghavi
authors.affiliation: c Department of Infectious Diseases , The University of Texas, M.D. Anderson Cancer Center , Houston , TX , USA.
authors.forename: Harrys A
authors.initials: HA
authors.lastname: Torres
authors.affiliation: a Department of Leukemia , The University of Texas, M.D. Anderson Cancer Center , Houston , TX , USA ;
authors.forename: Zeev
authors.initials: Z
authors.lastname: Estrov
authors.affiliation: b Department of Hematopathology , The University of Texas, M.D. Anderson Cancer Center , Houston , TX , USA ;
authors.forename: Keyur P
authors.initials: KP
authors.lastname: Patel
authors.affiliation: a Department of Leukemia , The University of Texas, M.D. Anderson Cancer Center , Houston , TX , USA ;
authors.forename: Naveen
authors.initials: N
authors.lastname: Pemmaraju
mesh_terms: D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000235:genetics*; D000090205:DNA Methyltransferase 3A; D004268:DNA-Binding Proteins / Q000235:genetics*; D049308:Dioxygenases; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011087:Polycythemia Vera / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D012074:Remission Induction; D013997:Time Factors
chemical_list: D004268:DNA-Binding Proteins; C000717967:DNMT3A protein, human; D011518:Proto-Oncogene Proteins; D049308:Dioxygenases; C541081:TET2 protein, human; D004248:DNA (Cytosine-5-)-Methyltransferases; D000090205:DNA Methyltransferase 3A; C507924:JAK2 protein, human; D053614:Janus Kinase 2